Health LiteracyCLEAR-PCNCT07437482
Cancer Literacy Education and Awareness Resources for Prostate Care
An observational study of Health Literacy and Prostate Cancer, run by Universidad Miguel Hernandez de Elche at 1 site in Spain.
Trial summary
The CLEAR-PC project addresses the critical issue of low health literacy in prostate cancer prevention and care, recognising that inadequate health literacy leads to difficulties in understanding complex medical information, limits shared decision making, and increases health inequalities. Read more about this study
- Who is it for?
- Ages 40 years and olderHealthy volunteers can take part
- Conditions the study is for
- Health Literacy, Prostate Cancer
- What is being tested?
- Co-created digital health literacy intervention for prostate cancer prevention and care
- How many people
- 3,100 participants
- Where
- 1 siteSpain
- Study dates
- Mar 2026to Sep 2028
- How long will I take part?
- 3 Years
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 40 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Study population: Study participants will be recruited from the general population, patients, caregivers, and healthcare professionals in participating European countries, including Spain, Portugal, Belgium, the Netherlands, and Croatia. The population will primarily include adults aged 40 years and older, reflecting the age group at risk for prostate cancer, as well as healthcare professionals involved in prostate cancer care and communication. Recruitment will take place through healthcare centres, patient organisations, community groups, and professional networks. The study will aim to include individuals from diverse socioeconomic, educational, and cultural backgrounds, including vulnerable populations such as migrants, minorities, and people with lower digital or health literacy levels, to ensure that the intervention is relevant and applicable across different social contexts.
Who may be able to join
- Adults aged 40 years or older
- Member of the general population, patient, caregiver, or healthcare professional eligible for the study component
- Able to understand and communicate in the language used at the study site
- Able to provide informed consent
- Willing to participate in surveys, interviews, workshops, or intervention activities as applicable
- Access to digital or non-digital materials required for the intervention, depending on study arm
Who cannot join
- Participation in another study that could interfere with the outcomes of this study
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
About this study
The CLEAR-PC project addresses the critical issue of low health literacy in prostate cancer prevention and care, recognising that inadequate health literacy leads to difficulties in understanding complex medical information, limits shared decision making, and increases health inequalities. Given the high prevalence and complexity of prostate cancer, the project aims to design and development of a comprehensive strategy to improve health literacy in the Prostate cancer prevention and care, considering individual capacities, the role of healthcare professionals and organisations, and the influence of social and cultural contexts. In the design and development of this new strategy, the investigators apply both action research and cocreation methodologies because by involving all stakeholders (general population, vulnerable population patients, health professionals, policy makers and other target groups), we ensure that the resulting strategy is user-centred, implementable and responsive to their needs. The design and development of the new strategy will follow a systematic cycle: (a) problem diagnosis by assessing individual contexts, healthcare professionals, organisational aspects and the social framework; (b) adaptation of existing health literacy tools to the specific context of prostate cancer prevention and care, integrating them into a new strategy, followed by evaluation of their usability and acceptability; and (c) observation of results in practice and reflection. Co-creation will be a critical component throughout this process, ensuring that stakeholders are actively involved at every stage, from diagnosis of challenges to refinement and validation of solutions. The consortium, composed of institutions from Spain, Portugal, Croatia, Belgium, the Netherlands and Cyprus, leverages multidisciplinary expertise to create digital and non-innovative tools and educational resources to address public health disparities, reduce misinformation and support decision-making on prostate cancer prevention and care.
Read the detailed description
Introduction Prostate cancer is one of the most common cancers in men worldwide and in Europe. Many men face difficult decisions about screening, diagnosis, treatment, and long-term care. These decisions often involve complex information, uncertainty about risks and benefits, and emotional stress.
At the same time, many people struggle to understand medical information or to assess whether information found online is reliable. This difficulty is known as limited health literacy-the ability to find, understand, evaluate, and use health information to make decisions. Today, health literacy also includes digital health literacy, which refers to the skills needed to use digital tools, websites, and online resources related to health.
Low levels of health literacy can lead to delayed diagnosis, misunderstanding of treatment options, reduced participation in shared decision-making with healthcare professionals, and inequalities in health outcomes. These challenges can be especially serious in prostate cancer, where decisions are complex and often depend on personal values and preferences.
The CLEAR-PC project was created to address this challenge by developing a comprehensive strategy to improve health literacy and digital health literacy related to prostate cancer prevention, diagnosis, treatment decisions, and palliative care. The study aims to help patients, caregivers, healthcare professionals, and the general public better understand prostate cancer and participate actively in decisions about care.
Overall aim of the study
The main goal of CLEAR-PC is to design, develop, and evaluate a strategy that improves health literacy and digital health literacy in prostate cancer care. This strategy will help people:
Access reliable and understandable information Understand risks and benefits of screening and treatment Participate in shared decision-making with healthcare professionals Reduce misinformation and confusion Improve communication between patients and clinicians Reduce inequalities in access to information and care
To achieve this, the project uses a multi-level approach that addresses:
Individuals and the information they receive Healthcare professionals and healthcare organizations Social, cultural, and environmental factors that influence health decisions
Participants in the study include:
Members of the general population Patients with prostate cancer Caregivers and family members Healthcare professionals (such as doctors, nurses, and psychologists) Researchers and educators Policy makers and health authorities Vulnerable or underserved populations The inclusion of diverse participants helps ensure that the tools and materials developed are practical, inclusive, and relevant to real-world needs.
Procedure CLEAR-PC follows an action-research and co-creation approach. Action research means that researchers do not only study a problem-they actively work with stakeholders to develop and test solutions in real settings. Co-creation means that patients, healthcare professionals, and other stakeholders participate in designing tools and strategies from the beginning, ensuring that the results are useful and easy to apply in practice.
The project progresses through three main phases.
Phase 1: Understanding needs and identifying gaps.
The first phase focuses on understanding current levels of health literacy and identifying barriers to informed decision-making. Researchers collect information using several methods:
Surveys: Large surveys are conducted among adults in several European countries to assess:
Knowledge about prostate cancer Ability to understand health information Use of digital health resources Confidence in making health decisions These surveys help identify gaps in knowledge and skills and show which groups may need additional support.
Focus groups: Group discussions are organized with:
Patients Caregivers Healthcare professionals Members of the general population People from vulnerable or minority communities These discussions provide insights into real experiences, challenges, and information needs.
Interviews Researchers also interview experts and policy makers to understand how health literacy can be improved at the healthcare system level.
Review of existing tools and programs: The project reviews existing educational materials, digital tools, and training programs used in Europe and internationally to improve health literacy. This helps identify best practices and areas that need improvement.
At the end of this phase, researchers have a clear picture of:
Current levels of knowledge and digital skills Barriers to understanding health information Needs of patients and professionals Existing resources that can be adapted
Phase 2: Designing and developing solutions In the second phase, researchers and stakeholders work together to design new tools and educational resources.
These may include:
Decision aids that help patients understand treatment options Educational videos and fact sheets Training programs for healthcare professionals Communication tools to explain risks and benefits clearly Digital platforms and online resources Community awareness materials These tools are tested in workshops and adapted to ensure they are understandable, culturally appropriate, and practical for different healthcare settings.
The aim is to create a CLEAR-PC strategy, a structured set of tools, materials, and best practices that can be used in real healthcare environments.
Phase 3: Testing the strategy in practice
Once the tools are developed, they are tested in clinical settings. This phase evaluates:
Whether patients better understand their condition Whether healthcare professionals communicate more effectively Whether patients feel more confident in making decisions Whether shared decision-making improves The results of this phase help refine the strategy before broader implementation.
Expected results
The study aims to produce several important outcomes:
Reliable and accessible educational materials about prostate cancer Training programs for healthcare professionals Tools that support shared decision-making Policy recommendations to improve communication and patient support A digital library of resources Strategies to combat misinformation
In the short term, the project will improve awareness and professional training. In the medium term, it will improve decision-making and communication. In the long term, it aims to reduce inequalities and improve health outcomes.
- Conditions
- Health Literacy, Prostate Cancer
- Being tested
- Co-created digital health literacy intervention for prostate cancer prevention and care
- Keywords
- Prostate cancer, Health literacy, Diagnosis, Screening, Treatment, Palliative care
- Medical subject headings
- Prostatic Neoplasms, Disease
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Co-created digital health literacy intervention for prostate cancer prevention and careOther
This intervention differs from other prostate cancer education or decision-support programmes because it uses a multilevel approach, targeting patients, healthcare professionals, organisations, and the social context that influences health decisions. It is developed through co-creation and action-research, meaning that patients, caregivers, clinicians, and policy makers participate in designing and refining the tools to ensure usability and cultural relevance. The intervention combines digital and non-digital components, including decision aids, educational materials, and professional training specifically tailored to prostate cancer screening, treatment decision-making, and palliative care. It also explicitly considers social determinants of health and includes strategies for vulnerable populations to reduce inequalities. Finally, the strategy is piloted and evaluated in clinical practice to assess its impact on patient understanding, shared decision-making, and communication skills.
| Study group | Role | What they receive |
|---|---|---|
| Participants receiving the CLEAR-PC health literacy intervention | This cohort includes participants exposed to the CLEAR-PC intervention, a multilevel strategy designed to improve digital health literacy and shared decision-making in prostate cancer prevention and care. The intervention includes educational materials, decision aids, and communication resources tailored to prostate cancer screening, treatment decision-making, and palliative care. It also provides training and support resources for healthcare professionals to improve patient communication. The strategy is developed through co-creation with patients, clinicians, and stakeholders and considers social determinants of health, including the needs of vulnerable populations. The intervention may be delivered through digital platforms, printed materials, workshops, or clinical consultations, depending on the study setting, and is evaluated for its impact on patient understanding, confidence in decision-making, and communication outcomes. Receives: Other: Co-created digital health literacy intervention for prostate cancer prevention and care |
What is being measured
The primary outcome is the main question the study is designed to answer.
Shared decision-making
Implementation of shared decision-making between healthcare professionals and patients during prostate cancer screening, treatment decision-making, and palliative care consultations will be assessed using validated questionnaires: the Shared Decision-Making Questionnaire for patients (SDM-Q-9) and the Shared Decision-Making Questionnaire for physicians (SDM-Q-Doc). Scores from these instruments will be transformed to a 0-100 scale, with higher scores indicating greater levels of shared decision-making. Differences in SDM scores between the intervention group (use of the CLEAR-PC strategy) and the control group (usual care) will be analyzed.
Units of Measurement: SDM-Q-9 and SDM-Q-Doc score (0-100 scale).
Measured: Baseline (prior to implementation of the CLEAR-PC strategy) and immediately post-intervention (at completion of the pilot implementation phase).
Secondary outcomes (4)
Prostate cancer knowledge
Change in patient knowledge regarding prostate cancer screening, diagnosis, and treatment will be assessed using the Prostate Cancer Knowledge Questionnaire (PCKQ-12). The questionnaire evaluates knowledge about symptoms, risk factors, screening recommendations, diagnosis, and treatment side effects. Higher scores indicate greater knowledge of prostate cancer.
Units of Measurement: PCKQ-12 total score (0-12 points).
Measured: Baseline (prior to implementation of the CLEAR-PC strategy) and immediately post-intervention (at completion of the pilot implementation phase).
Patient satisfaction with care
Patient satisfaction with healthcare communication and consultation will be measured using the Patient Satisfaction Questionnaire (PSQ-18). This instrument evaluates satisfaction across several domains including communication, technical quality, and accessibility of care. Higher scores indicate greater satisfaction with care.
finalproposal Units of Measurement: PSQ-18 score (Likert scale; total or domain scores).
Measured: Baseline (prior to implementation of the CLEAR-PC strategy) and immediately post-intervention (at completion of the pilot implementation phase).
Emotional and psychological well-being
Emotional distress related to prostate cancer screening, diagnosis, or treatment will be assessed using the Emotional Distress Thermometer (EDT). This tool measures patients' perceived distress related to their health condition and care process. Higher scores indicate greater emotional distress.
finalproposal Units of Measurement: Distress score (0-10 scale).
Measured: Baseline (prior to implementation of the CLEAR-PC strategy) and immediately post-intervention (at completion of the pilot implementation phase).
Usability and educational value of the CLEAR-PC strategy
Healthcare professionals and patients will provide feedback on the usability, educational usefulness, and communication support of the CLEAR-PC strategy through an ad-hoc questionnaire developed for the study. This will evaluate how easy the strategy is to use and its perceived usefulness in improving communication and understanding during consultations.
finalproposal Units of Measurement: Likert-scale questionnaire scores.
Measured: Baseline (prior to implementation of the CLEAR-PC strategy) and immediately post-intervention (at completion of the pilot implementation phase).
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted27 Feb 2026
- Study startMar 2026 (estimated)
- Primary completionMar 2028 (estimated)
- Study completionSep 2028 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Health LiteracyStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Cross-sectional
- Enrolment
- 3,100 participants (estimated)
- Target duration
- 3 Years
Sponsor and investigators
- Lead sponsor
- Universidad Miguel Hernandez de Elche
- Sponsor type
- University, hospital or other
- Collaborators
- Canary Islands Health Service, Ordem dos Psicólogos, Public Open University Čakovec, Thomas More University of Applied Sciences, Erasmus Medical Center, Center for Social Innovation, Instituto de Investigación Sanitaria y Biomédica de Alicante, Europa UOMO, Spanish Society of Family and Community Medicine, Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana, Universidad de Murcia, Fundación Canaria Instituto de Investigación Sanitaria de Canarias, FEFOC fundation, Ministry of Health - Government of the Principality of Asturias, Asturias Public Health Service (SESPA), Fundacion para el Fomento en Asturias de la Investigacion Cientifica Aplicada y Tecnologia
- Responsible party
- Principal investigator, Blanca Juana Lumbreras Lacarra, Universidad Miguel Hernandez de Elche
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07437482
- Sponsor's protocol ID
- 101219353
- Other IDs
- 101219353
- Acronym
- CLEAR-PC
- Status last verified
- Feb 2026
- First submitted
- 14 Feb 2026
- Last updated
- 3 Mar 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 3 Mar 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Cancer Literacy Education and Awareness Resources for Prostate Care
- ClinicalTrials.gov ID
- NCT07437482
- Acronym / sponsor ID
- CLEAR-PC / 101219353
- Conditions
- Health Literacy, Prostate Cancer
- Keywords
- Prostate cancer, Health literacy, Diagnosis, Screening, Treatment, Palliative care
- Study type
- Observational
- Recruitment status
- Not yet recruiting
- Enrolment
- 3,100 participants (estimated)
- Lead sponsor
- Universidad Miguel Hernandez de ElcheUniversity, hospital or other
- Collaborators
- Canary Islands Health Service, Ordem dos Psicólogos, Public Open University Čakovec, Thomas More University of Applied Sciences, Erasmus Medical Center, Center for Social Innovation, Instituto de Investigación Sanitaria y Biomédica de Alicante, Europa UOMO, Spanish Society of Family and Community Medicine, Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana, Universidad de Murcia, Fundación Canaria Instituto de Investigación Sanitaria de Canarias, FEFOC fundation, Ministry of Health - Government of the Principality of Asturias, Asturias Public Health Service (SESPA), Fundacion para el Fomento en Asturias de la Investigacion Cientifica Aplicada y Tecnologia
- Study start
- Mar 2026 (estimated)
- Primary completion
- Mar 2028 (estimated)
- Study completion
- Sep 2028 (estimated)
- First posted
- 27 Feb 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The CLEAR-PC project addresses the critical issue of low health literacy in prostate cancer prevention and care, recognising that inadequate health literacy leads to difficulties in understanding complex medical information, limits shared decision making, and increases health inequalities. Given the high prevalence and complexity of prostate cancer, the project aims to design and development of a comprehensive strategy to improve health literacy in the Prostate cancer prevention and care, considering individual capacities, the role of healthcare professionals and organisations, and the influence of social and cultural contexts. In the design and development of this new strategy, the investigators apply both action research and cocreation methodologies because by involving all stakeholders (general population, vulnerable population patients, health professionals, policy makers and other target groups), we ensure that the resulting strategy is user-centred, implementable and responsive to their needs. The design and development of the new strategy will follow a systematic cycle: (a) problem diagnosis by assessing individual contexts, healthcare professionals, organisational aspects and the social framework; (b) adaptation of existing health literacy tools to the specific context of prostate cancer prevention and care, integrating them into a new strategy, followed by evaluation of their usability and acceptability; and (c) observation of results in practice and reflection. Co-creation will be a critical component throughout this process, ensuring that stakeholders are actively involved at every stage, from diagnosis of challenges to refinement and validation of solutions. The consortium, composed of institutions from Spain, Portugal, Croatia, Belgium, the Netherlands and Cyprus, leverages multidisciplinary expertise to create digital and non-innovative tools and educational resources to address public health disparities, reduce misinformation and support decision-making on prostate cancer prevention and care.
Detailed description
Introduction Prostate cancer is one of the most common cancers in men worldwide and in Europe. Many men face difficult decisions about screening, diagnosis, treatment, and long-term care. These decisions often involve complex information, uncertainty about risks and benefits, and emotional stress.
At the same time, many people struggle to understand medical information or to assess whether information found online is reliable. This difficulty is known as limited health literacy-the ability to find, understand, evaluate, and use health information to make decisions. Today, health literacy also includes digital health literacy, which refers to the skills needed to use digital tools, websites, and online resources related to health.
Low levels of health literacy can lead to delayed diagnosis, misunderstanding of treatment options, reduced participation in shared decision-making with healthcare professionals, and inequalities in health outcomes. These challenges can be especially serious in prostate cancer, where decisions are complex and often depend on personal values and preferences.
The CLEAR-PC project was created to address this challenge by developing a comprehensive strategy to improve health literacy and digital health literacy related to prostate cancer prevention, diagnosis, treatment decisions, and palliative care. The study aims to help patients, caregivers, healthcare professionals, and the general public better understand prostate cancer and participate actively in decisions about care.
Overall aim of the study
The main goal of CLEAR-PC is to design, develop, and evaluate a strategy that improves health literacy and digital health literacy in prostate cancer care. This strategy will help people:
Access reliable and understandable information Understand risks and benefits of screening and treatment Participate in shared decision-making with healthcare professionals Reduce misinformation and confusion Improve communication between patients and clinicians Reduce inequalities in access to information and care
To achieve this, the project uses a multi-level approach that addresses:
Individuals and the information they receive Healthcare professionals and healthcare organizations Social, cultural, and environmental factors that influence health decisions
Participants in the study include:
Members of the general population Patients with prostate cancer Caregivers and family members Healthcare professionals (such as doctors, nurses, and psychologists) Researchers and educators Policy makers and health authorities Vulnerable or underserved populations The inclusion of diverse participants helps ensure that the tools and materials developed are practical, inclusive, and relevant to real-world needs.
Procedure CLEAR-PC follows an action-research and co-creation approach. Action research means that researchers do not only study a problem-they actively work with stakeholders to develop and test solutions in real settings. Co-creation means that patients, healthcare professionals, and other stakeholders participate in designing tools and strategies from the beginning, ensuring that the results are useful and easy to apply in practice.
The project progresses through three main phases.
Phase 1: Understanding needs and identifying gaps.
The first phase focuses on understanding current levels of health literacy and identifying barriers to informed decision-making. Researchers collect information using several methods:
Surveys: Large surveys are conducted among adults in several European countries to assess:
Knowledge about prostate cancer Ability to understand health information Use of digital health resources Confidence in making health decisions These surveys help identify gaps in knowledge and skills and show which groups may need additional support.
Focus groups: Group discussions are organized with:
Patients Caregivers Healthcare professionals Members of the general population People from vulnerable or minority communities These discussions provide insights into real experiences, challenges, and information needs.
Interviews Researchers also interview experts and policy makers to understand how health literacy can be improved at the healthcare system level.
Review of existing tools and programs: The project reviews existing educational materials, digital tools, and training programs used in Europe and internationally to improve health literacy. This helps identify best practices and areas that need improvement.
At the end of this phase, researchers have a clear picture of:
Current levels of knowledge and digital skills Barriers to understanding health information Needs of patients and professionals Existing resources that can be adapted
Phase 2: Designing and developing solutions In the second phase, researchers and stakeholders work together to design new tools and educational resources.
These may include:
Decision aids that help patients understand treatment options Educational videos and fact sheets Training programs for healthcare professionals Communication tools to explain risks and benefits clearly Digital platforms and online resources Community awareness materials These tools are tested in workshops and adapted to ensure they are understandable, culturally appropriate, and practical for different healthcare settings.
The aim is to create a CLEAR-PC strategy, a structured set of tools, materials, and best practices that can be used in real healthcare environments.
Phase 3: Testing the strategy in practice
Once the tools are developed, they are tested in clinical settings. This phase evaluates:
Whether patients better understand their condition Whether healthcare professionals communicate more effectively Whether patients feel more confident in making decisions Whether shared decision-making improves The results of this phase help refine the strategy before broader implementation.
Expected results
The study aims to produce several important outcomes:
Reliable and accessible educational materials about prostate cancer Training programs for healthcare professionals Tools that support shared decision-making Policy recommendations to improve communication and patient support A digital library of resources Strategies to combat misinformation
In the short term, the project will improve awareness and professional training. In the medium term, it will improve decision-making and communication. In the long term, it aims to reduce inequalities and improve health outcomes.
Study design
- Observational model
- Other
- Time perspective
- Cross-sectional
- Target follow-up
- 3 Years
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Participants receiving the CLEAR-PC health literacy intervention | – | Other: Co-created digital health literacy intervention for prostate cancer prevention and careThis cohort includes participants exposed to the CLEAR-PC intervention, a multilevel strategy designed to improve digital health literacy and shared decision-making in prostate cancer prevention and care. The intervention includes educational materials, decision aids, and communication resources tailored to prostate cancer screening, treatment decision-making, and palliative care. It also provides training and support resources for healthcare professionals to improve patient communication. The strategy is developed through co-creation with patients, clinicians, and stakeholders and considers social determinants of health, including the needs of vulnerable populations. The intervention may be delivered through digital platforms, printed materials, workshops, or clinical consultations, depending on the study setting, and is evaluated for its impact on patient understanding, confidence in decision-making, and communication outcomes. |
Who may qualify
- Ages
- 40 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- Study participants will be recruited from the general population, patients, caregivers, and healthcare professionals in participating European countries, including Spain, Portugal, Belgium, the Netherlands, and Croatia. The population will primarily include adults aged 40 years and older, reflecting the age group at risk for prostate cancer, as well as healthcare professionals involved in prostate cancer care and communication. Recruitment will take place through healthcare centres, patient organisations, community groups, and professional networks. The study will aim to include individuals from diverse socioeconomic, educational, and cultural backgrounds, including vulnerable populations such as migrants, minorities, and people with lower digital or health literacy levels, to ensure that the intervention is relevant and applicable across different social contexts.
Key inclusion criteria (6 listed)
- Adults aged 40 years or older
- Member of the general population, patient, caregiver, or healthcare professional eligible for the study component
- Able to understand and communicate in the language used at the study site
- Able to provide informed consent
- Willing to participate in surveys, interviews, workshops, or intervention activities as applicable
Key exclusion criteria (1 listed)
- Participation in another study that could interfere with the outcomes of this study
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Co-created digital health literacy intervention for prostate cancer prevention and careThis intervention differs from other prostate cancer education or decision-support programmes because it uses a multilevel approach, targeting patients, healthcare professionals, organisations, and the social context that influences health decisions. It is developed through co-creation and action-research, meaning that patients, caregivers, clinicians, and policy makers participate in designing and refining the tools to ensure usability and cultural relevance. The intervention combines digital and non-digital components, including decision aids, educational materials, and professional training specifically tailored to prostate cancer screening, treatment decision-making, and palliative care. It also explicitly considers social determinants of health and includes strategies for vulnerable populations to reduce inequalities. Finally, the strategy is piloted and evaluated in clinical practice to assess its impact on patient understanding, shared decision-making, and communication skills. | Other | Participants receiving the CLEAR-PC health literacy intervention |
Primary outcome
Shared decision-making
Time frame: Baseline (prior to implementation of the CLEAR-PC strategy) and immediately post-intervention (at completion of the pilot implementation phase).
Implementation of shared decision-making between healthcare professionals and patients during prostate cancer screening, treatment decision-making, and palliative care consultations will be assessed using validated questionnaires: the Shared Decision-Making Questionnaire for patients (SDM-Q-9) and the Shared Decision-Making Questionnaire for physicians (SDM-Q-Doc). Scores from these instruments will be transformed to a 0-100 scale, with higher scores indicating greater levels of shared decision-making. Differences in SDM scores between the intervention group (use of the CLEAR-PC strategy) and the control group (usual care) will be analyzed. Units of Measurement: SDM-Q-9 and SDM-Q-Doc score (0-100 scale).
4 secondary outcomes
Prostate cancer knowledge
Time frame: Baseline (prior to implementation of the CLEAR-PC strategy) and immediately post-intervention (at completion of the pilot implementation phase).
Patient satisfaction with care
Time frame: Baseline (prior to implementation of the CLEAR-PC strategy) and immediately post-intervention (at completion of the pilot implementation phase).
Emotional and psychological well-being
Time frame: Baseline (prior to implementation of the CLEAR-PC strategy) and immediately post-intervention (at completion of the pilot implementation phase).
Usability and educational value of the CLEAR-PC strategy
Time frame: Baseline (prior to implementation of the CLEAR-PC strategy) and immediately post-intervention (at completion of the pilot implementation phase).
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 3 Mar 2026.
- Related InfoLink provided by the sponsor.
- Individual participant dataSharing planned: Undecided
Related trials for Health Literacy
Recruiting
Evaluating the Impact of Using the B-OK Bottles for HIV and ART Literacy in South Africa
HIV, HIV Treatment
Active, not recruiting
Designing and Evaluating a Classroom-Based Mental Health Programme for Adolescents.
Mental Health Promotion
Not yet recruiting
Advancing Cardiovascular Health Among Adolescents With Intellectual Disabilities: Co-Development of Technology Interventions to Enhance Physical Activity
Physical Activity, Intellectual Disabilities
Not yet recruiting
Community Health Worker Nutrition Self-Management Support for Cardio-Kidney-Metabolic Health
Hypertension (HTN), CKD - Chronic Kidney Disease
Not yet recruiting
Sperm, Exposure and Endocrine Disruptors
Fertility, Male Fertility
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Health Literacy and Prostate Cancer, run by Universidad Miguel Hernandez de Elche at 1 site in Spain.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 6 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 3 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Blanca Lumbreras, PhD (+34965919510, blumbreras@umh.es), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Shared decision-making (time frame: Baseline (prior to implementation of the CLEAR-PC strategy) and immediately post-intervention (at completion of the pilot implementation phase).). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Mar 2026.